260 related articles for article (PubMed ID: 18413488)
41. ACE inhibitor-induced angioedema: a case report and review of current management.
Kloth N; Lane AS
Crit Care Resusc; 2011 Mar; 13(1):33-7. PubMed ID: 21355827
[TBL] [Abstract][Full Text] [Related]
42. Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy.
Korniyenko A; Alviar CL; Cordova JP; Messerli FH
Cleve Clin J Med; 2011 May; 78(5):297-304. PubMed ID: 21536824
[TBL] [Abstract][Full Text] [Related]
43. Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?
Sica DA; Black HR
J Clin Hypertens (Greenwich); 2002; 4(5):375-80. PubMed ID: 12368584
[TBL] [Abstract][Full Text] [Related]
44. Epidemiology of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record.
Banerji A; Blumenthal KG; Lai KH; Zhou L
J Allergy Clin Immunol Pract; 2017; 5(3):744-749. PubMed ID: 28377081
[TBL] [Abstract][Full Text] [Related]
45. Perioperative angioedema in a patient on long-term angiotensin-converting enzyme (ACE)-inhibitor therapy.
Ogbureke KU; Cruz C; Johnson JV; Helfrick JF
J Oral Maxillofac Surg; 1996 Jul; 54(7):917-20. PubMed ID: 8676243
[No Abstract] [Full Text] [Related]
46. Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use.
Byrd JB; Woodard-Grice A; Stone E; Lucisano A; Schaefer H; Yu C; Eyler AE; Salloum NE; Brown NJ
Allergy; 2010 Nov; 65(11):1381-7. PubMed ID: 20557296
[TBL] [Abstract][Full Text] [Related]
47. Pollen count and presentation of angiotensin-converting enzyme inhibitor-associated angioedema.
Straka B; Nian H; Sloan C; Byrd JB; Woodard-Grice A; Yu C; Stone E; Steven G; Hartert T; Teo KK; Pare G; McCarty CA; Brown NJ
J Allergy Clin Immunol Pract; 2013; 1(5):468-73.e1-4. PubMed ID: 24565618
[TBL] [Abstract][Full Text] [Related]
48. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
49. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.
Fok JS; Katelaris CH; Brown AF; Smith WB
Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565
[TBL] [Abstract][Full Text] [Related]
50. ACE Inhibitor-Induced Angioedema: a Review.
Kostis WJ; Shetty M; Chowdhury YS; Kostis JB
Curr Hypertens Rep; 2018 Jun; 20(7):55. PubMed ID: 29884969
[TBL] [Abstract][Full Text] [Related]
51. [ACE inhibitor-induced angioedema: remarkable new perspectives for intensive care/emergency medicine].
Wernze H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):637-41. PubMed ID: 9825047
[TBL] [Abstract][Full Text] [Related]
52. Thirty-day mortality risk associated with the postoperative nonresumption of angiotensin-converting enzyme inhibitors: a retrospective study of the Veterans Affairs Healthcare System.
Mudumbai SC; Takemoto S; Cason BA; Au S; Upadhyay A; Wallace AW
J Hosp Med; 2014 May; 9(5):289-96. PubMed ID: 24799360
[TBL] [Abstract][Full Text] [Related]
53. [Angioedema caused by inhibitors of angiotensin converting enzyme (ACE) and angiotensin II receptor blockers].
Panaszek B; Małolepszy J
Pol Arch Med Wewn; 2004 Jan; 111(1):113-7. PubMed ID: 15088431
[No Abstract] [Full Text] [Related]
54. Antihypertensive medication use in the Department of Veterans Affairs: a national analysis of prescribing patterns from 2000 to 2002.
Lopez J; Meier J; Cunningham F; Siegel D
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1095-9. PubMed ID: 15607614
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin-converting enzyme inhibitor (ACE-I)- and angiotensin receptor blocker (ARB)-related angioedema: a neglected issue in daily practice in Greece.
Symvoulakis EK; Kyrmizakis DE; Drivas EI; Bizakis J; Velegrakis GA; Lionis C
Eur J Gen Pract; 2007; 13(4):239-41. PubMed ID: 18324507
[TBL] [Abstract][Full Text] [Related]
56. [OCTAVE and OPERA: discordance in hypertension therapy?].
Philipp S; Dietz R; Willenbrock R
Herz; 2004 May; 29(3):266-70. PubMed ID: 15167952
[TBL] [Abstract][Full Text] [Related]
57. Multicentre audit of ACE-inhibitor associated angioedema (MAAAA).
Gandhi J; Jones R; Teubner D; Gabb G
Aust Fam Physician; 2015 Aug; 44(8):579-83. PubMed ID: 26510147
[TBL] [Abstract][Full Text] [Related]
58. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
59. ACE inhibitor-induced angioedema. Incidence, prevention and management.
Vleeming W; van Amsterdam JG; Stricker BH; de Wildt DJ
Drug Saf; 1998 Mar; 18(3):171-88. PubMed ID: 9530537
[TBL] [Abstract][Full Text] [Related]
60. Angiotensin-converting enzyme inhibitor-associated angioedema.
Byrd JB; Adam A; Brown NJ
Immunol Allergy Clin North Am; 2006 Nov; 26(4):725-37. PubMed ID: 17085287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
